Concepedia

Akiko Kurimoto

AK

Statistics

Publications

6

Citations

408

H-Index

6

Active since

2015

Affiliations

Daiichi-Sankyo (Japan)(Current)

The University of Tokyo

RIKEN Center for Integrative Medical Sciences

Daiichi Sankyo (Germany)

Akiko Kurimoto is an author at Daiichi-Sankyo (Japan) specializing in medicine, molecular oncology, and colorectal cancer.

Publications per year

2015–2023

6

Publications

6

Long noncoding RNA <i>UPAT</i> promotes colon tumorigenesis by inhibiting degradation of UHRF1

Kenzui Taniue, Akiko Kurimoto, Hironobu Sugimasa et al. · Proceedings of the National Academy of Sciences · 2016 · 161 citations · Full text

, , +15

<i>ASBEL</i> –TCF3 complex is required for the tumorigenicity of colorectal cancer cells

Kenzui Taniue, Akiko Kurimoto, Yasuko Takeda et al. · Proceedings of the National Academy of Sciences · 2016 · 82 citations · Full text

, , +17

UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells

Kenzui Taniue, Tomoatsu Hayashi, Yuki Kamoshida et al. · Oncogene · 2019 · 73 citations

, , +14

Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells

Hironobu Sugimasa, Kenzui Taniue, Akiko Kurimoto et al. · Biochemical and Biophysical Research Communications · 2015 · 44 citations

, , +11

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi et al. · Cancer Cell International · 2023 · 29 citations · Full text

, , +13

1–5 of 6